Cancer Letters
Volume 275, Issue 1 , Pages 35-43 , 8 March 2009

BMP7 influences proliferation, migration, and invasion of breast cancer cells

Received 25 June 2008 ,Revised 26 September 2008 ,Accepted 30 September 2008.

References 

  1. Ye L, Lewis-Russell JM, Kyanaston HG, Jiang WG. Bone morphogenetic proteins and their receptor signaling in prostate cancer. Histol. Histopathol. 2007;22:1129–1147
  2. Botchkarev VA. Bone morphogenetic proteins and their antagonists in skin and hair follicle biology. J. Invest. Dermatol. 2003;120:36–47
  3. Miyazono K, Maeda S, Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 2005;16:251–263
  4. Kawabata M, Imamura T, Miyazono K. Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev. 1998;9:49–61
  5. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev. 2005;19:2783–2810
  6. Balemans W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators. Dev. Biol. 2002;250:231–250
  7. Derynck R, Zhang YE. Smad-dependent and smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577–584
  8. von Bubnoff A, Cho KW. Intracellular BMP signaling regulation in vertebrates: pathway or network?. Dev. Biol. 2001;239:1–14
  9. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, et al. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 1992;267:20352–20362
  10. Wozney JM. Overview of bone morphogenetic proteins. Spine. 2002;27:S2–S8
  11. Ducy P, Karsenty G. The family of bone morphogenetic proteins. Kidney Int. 2000;57:2207–2214
  12. Patel SR, Dressler GR. BMP7 signaling in renal development and disease. Trends Mol. Med. 2005;11:512–518
  13. Yang S, Lim M, Pham LK, Kendall SE, Reddi AH, Altieri DC, et al. Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both smad and c-jun NH2-terminal kinase pathways. Cancer Res. 2006;66:4285–4290
  14. Yang S, Zhong C, Frenkel B, Reddi AH, Roy-Burman P. Diverse biological effect and smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res. 2005;65:5769–5777
  15. Miyazaki H, Watabe T, Kitamura T, Miyazono K. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells. Oncogene. 2004;23:9326–9335
  16. Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, et al. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. J. Bone Miner. Res. 2005;20:2189–2199
  17. Ye L, Lewis-Russell JM, Kynaston H, Jiang WG. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists. J. Urol. 2007;178:1086–1091
  18. Franzen A, Heldin NE. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1). Biochem. Biophys. Res. Commun. 2001;285:773–781
  19. Baade Ro T, Utne Holt R, Brenne AT, Hjorth-Hansen H, Waage A, Hjertner O, et al. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene. 2004;23:3024–3032
  20. Beck SE, Jung BH, Fiorino A, Gomez J, Rosario ED, Cabrera BL, et al. Bone morphogenetic protein signaling and growth suppression in colon cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 2006;291:G135–G145
  21. Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, et al. Clinical significance of BMP7 in human colorectal cancer. Ann. Surg. Oncol. 2008;15:1530–1537
  22. Masuda H, Fukabori Y, Nakano K, Takezawa Y, CSuzuki T, Yamanaka H. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer. Prostate. 2003;54:268–274
  23. Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res. 2005;65:448–456
  24. Rothhammer T, Wild PJ, Meyer S, Bataille F, Pauer A, Klinkhammer-Schalke M, et al. Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark. 2007;3:111–117
  25. Alarmo E-L, Kuukasjarvi T, Karhu R, Kallioniemi A. A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Res. Treat. 2007;103:239–246
  26. Alarmo E-L, Rauta J, Kauraniemi P, Karhu R, Kuukasjarvi T, Kallioniemi A. Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer. Genes Chromosomes Cancer. 2006;45:411–419
  27. Schwalbe M, Sanger J, Eggers R, Naumann A, Schmidt A, Hoffken K, et al. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer. Int. J. Oncol. 2003;23:89–95
  28. Alarmo E-L, Korhonen T, Kuukasjarvi T, Huhtala H, Holli K, Kallioniemi A. Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas. Ann. Oncol. 2008;19:308–314
  29. Parssinen J, Kuukasjarvi T, Karhu R, Kallioniemi A. High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer. Br. J. Cancer. 2007;96:1258–1264
  30. Parssinen J, Alarmo E-L, Karhu R, Kallioniemi A. PPM1D silencing by RNA interference inhibits proliferation and induces apoptosis in breast cancer cell lines with wild-type p53. Cancer Genet. Cytogenet. 2008;182:33–39
  31. W.S. Rasband, ImageJ, US National Institutes of Health, Bethesda, MD, USA. Available from: <http://rsb.info.nih.gov/ij/> (1997–2007).
  32. Massague J, Gomis RR. The logic of TGFbeta signaling. FEBS Lett. 2006;580:2811–2820
  33. Feeley BT, Krenek L, Liu N, Hsu WK, Gamradt SC, Schwarz EM, et al. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone. 2006;38:154–166
  34. Buijs JT, Henriquez NV, van Overveld PG, et al. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Res. 2007;67:8742–8751
  35. Buijs JT, Rentsch CA, van der Horst G, et al. BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am. J. Pathol. 2007;171:1047–1057
  36. Zhong D, Morikawa A, Guo L, Colpaert C, Xiong L, Nassar A, et al. Homozygous deletion of SMAD4 in breast cancer cell lines and invasive ductal carcinomas. Cancer Biol. Ther. 2006;5:601–607
  37. Iacobuzio-Donahue CA, Song J, Parmiagiani G, Yeo CJ, Hruban RH, Kern SE. Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors. Clin. Cancer Res. 2004;10:1597–1604
  38. Yan W, Chen X. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells. Cancer Res. 2007;67:9117–9124
  39. Wang N, Lin KK, Lu Z, Lam KS, Newton R, Xu X, et al. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells. Oncogene. 2007;26:6431–6441
  40. Bailey JM, Singh PK, Hollingsworth MA. Cancer metastasis facilitated by developmental pathways: sonic hedgehog, notch, and bone morphogenic proteins. J. Cell. Biochem. 2007;102:829–839
  41. Grijelmo C, Rodrigue C, Svrcek M, Bruyneel E, Hendrix A, de Wever O, et al. Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells. Cell. Signal. 2007;19:1722–1732
  42. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J. Bone Miner. Res. 2001;16:1486–1495

PII: S0304-3835(08)00798-2

doi: 10.1016/j.canlet.2008.09.028

Cancer Letters
Volume 275, Issue 1 , Pages 35-43 , 8 March 2009

Article Tools

* Image Usage & Resolution